Nuclear medicine scan has potential to identify which cancer patients could benefit from aromatase inhibitor treatment

A new, non-invasive nuclear medicine test can be used to determine whether aromatase inhibitor treatment will be effective for specific cancer patients, according to a recent study. The research shows that a PET scan with the ligand C-11-vorozole reliably detects aromatase in all body organs